Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash-to-Debt 5.00
CSII's Cash-to-Debt is ranked higher than
56% of the 331 Companies
in the Global Medical Devices industry.

( Industry Median: 2.87 vs. CSII: 5.00 )
Ranked among companies with meaningful Cash-to-Debt only.
CSII' s Cash-to-Debt Range Over the Past 10 Years
Min: 1.11  Med: 40.55 Max: No Debt
Current: 5
Equity-to-Asset 0.63
CSII's Equity-to-Asset is ranked lower than
53% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. CSII: 0.63 )
Ranked among companies with meaningful Equity-to-Asset only.
CSII' s Equity-to-Asset Range Over the Past 10 Years
Min: -1.4  Med: 0.52 Max: 0.94
Current: 0.63
-1.4
0.94
Debt-to-Equity 0.18
CSII's Debt-to-Equity is ranked higher than
62% of the 215 Companies
in the Global Medical Devices industry.

( Industry Median: 0.27 vs. CSII: 0.18 )
Ranked among companies with meaningful Debt-to-Equity only.
CSII' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.03  Med: 0.54 Max: 1.77
Current: 0.18
-0.03
1.77
Debt-to-EBITDA 8.23
CSII's Debt-to-EBITDA is ranked lower than
90% of the 156 Companies
in the Global Medical Devices industry.

( Industry Median: 1.98 vs. CSII: 8.23 )
Ranked among companies with meaningful Debt-to-EBITDA only.
CSII' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -1.35  Med: -0.58 Max: 8.23
Current: 8.23
-1.35
8.23
Piotroski F-Score: 7
Altman Z-Score: 6.28
Beneish M-Score: -2.99
WACC vs ROIC
14.38%
-4.40%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating Margin % -0.70
CSII's Operating Margin % is ranked lower than
56% of the 310 Companies
in the Global Medical Devices industry.

( Industry Median: 3.05 vs. CSII: -0.70 )
Ranked among companies with meaningful Operating Margin % only.
CSII' s Operating Margin % Range Over the Past 10 Years
Min: -60.63  Med: -21.58 Max: -0.7
Current: -0.7
-60.63
-0.7
Net Margin % -0.93
CSII's Net Margin % is ranked lower than
55% of the 310 Companies
in the Global Medical Devices industry.

( Industry Median: 1.62 vs. CSII: -0.93 )
Ranked among companies with meaningful Net Margin % only.
CSII' s Net Margin % Range Over the Past 10 Years
Min: -56.49  Med: -23.14 Max: -0.87
Current: -0.93
-56.49
-0.87
ROE % -1.69
CSII's ROE % is ranked lower than
56% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 1.53 vs. CSII: -1.69 )
Ranked among companies with meaningful ROE % only.
CSII' s ROE % Range Over the Past 10 Years
Min: -99.5  Med: -47.59 Max: -1.63
Current: -1.69
-99.5
-1.63
ROA % -1.10
CSII's ROA % is ranked lower than
52% of the 332 Companies
in the Global Medical Devices industry.

( Industry Median: 0.11 vs. CSII: -1.10 )
Ranked among companies with meaningful ROA % only.
CSII' s ROA % Range Over the Past 10 Years
Min: -58.12  Med: -30.3 Max: -1.07
Current: -1.1
-58.12
-1.07
ROC (Joel Greenblatt) % -2.04
CSII's ROC (Joel Greenblatt) % is ranked lower than
55% of the 326 Companies
in the Global Medical Devices industry.

( Industry Median: 4.41 vs. CSII: -2.04 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
CSII' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -4509.29  Med: -177.88 Max: -2.04
Current: -2.04
-4509.29
-2.04
3-Year Revenue Growth Rate 9.40
CSII's 3-Year Revenue Growth Rate is ranked higher than
65% of the 263 Companies
in the Global Medical Devices industry.

( Industry Median: 4.30 vs. CSII: 9.40 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
CSII' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 0  Med: -0.8 Max: 23.9
Current: 9.4
0
23.9
3-Year EPS without NRI Growth Rate -63.70
CSII's 3-Year EPS without NRI Growth Rate is ranked lower than
96% of the 231 Companies
in the Global Medical Devices industry.

( Industry Median: 1.70 vs. CSII: -63.70 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
CSII' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -66.2  Med: -11.8 Max: 81.2
Current: -63.7
-66.2
81.2
GuruFocus has detected 2 Warning Signs with Cardiovascular Systems Inc CSII.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» CSII's 30-Y Financials

Financials (Next Earnings Date: 2018-01-25)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q4 2016

CSII Guru Trades in Q4 2016

John Hussman 117,000 sh (New)
Paul Tudor Jones 18,806 sh (+44.66%)
Mario Gabelli 36,400 sh (unchged)
Steven Cohen Sold Out
Mairs and Power 75,762 sh (-0.32%)
Jim Simons 131,100 sh (-24.70%)
» More
Q1 2017

CSII Guru Trades in Q1 2017

Joel Greenblatt 8,465 sh (New)
Caxton Associates 8,691 sh (New)
Steven Cohen 55,389 sh (New)
John Hussman 200,000 sh (+70.94%)
Paul Tudor Jones 25,451 sh (+35.33%)
Mairs and Power 75,762 sh (unchged)
Mario Gabelli 36,400 sh (unchged)
Jim Simons 58,800 sh (-55.15%)
» More
Q2 2017

CSII Guru Trades in Q2 2017

Jim Simons 278,301 sh (+373.30%)
Steven Cohen 201,990 sh (+264.68%)
Joel Greenblatt 14,171 sh (+67.41%)
Mario Gabelli 41,500 sh (+14.01%)
Mairs and Power 75,762 sh (unchged)
John Hussman 200,000 sh (unchged)
Caxton Associates Sold Out
Paul Tudor Jones 21,517 sh (-15.46%)
» More
Q3 2017

CSII Guru Trades in Q3 2017

Steven Cohen 469,978 sh (+132.67%)
Mario Gabelli 81,430 sh (+96.22%)
Jim Simons 529,800 sh (+90.37%)
Paul Tudor Jones 21,648 sh (+0.61%)
Mairs and Power 75,762 sh (unchged)
John Hussman 200,000 sh (unchged)
Joel Greenblatt 7,296 sh (-48.51%)
» More
» Details

Insider Trades

Latest Guru Trades with CSII

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Mario Gabelli 2017-09-30 Add 96.22%$27.25 - $32.85 $ 24.15-21%81,430
Joel Greenblatt 2017-09-30 Reduce -48.51%$27.25 - $32.85 $ 24.15-21%7,296
Mario Gabelli 2017-06-30 Add 14.01%$28.11 - $32.89 $ 24.15-21%41,500
Joel Greenblatt 2017-06-30 Add 67.41%$28.11 - $32.89 $ 24.15-21%14,171
Joel Greenblatt 2017-03-31 New Buy$23.37 - $29.19 $ 24.15-9%8,465
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 339112    SIC: 3841
Compare:SZSE:300562, SZSE:300318, NAS:KTWO, SZSE:300206, NAS:XENT, XTER:SBS, NAS:OFIX, LSE:CSRT, SZSE:300314, SZSE:300642, TSE:4549, XBRU:IBAB, NYSE:CRY, NAS:AXGN, ROCO:8406, OTCPK:NMRD, SZSE:300326, SZSE:300238, NAS:EXAC, TSE:4548 » details
Traded in other countries:R7Y1.Germany,
Headquarter Location:USA
Cardiovascular Systems Inc is a medical technology company developing solutions for vascular and coronary disease. It treats patients suffering from peripheral and coronary artery diseases, including those with arterial calcium.

Cardiovascular Systems is a medical technology company focused on patients with peripheral and coronary artery diseases. Its peripheral artery disease systems are catheter-based platforms used to treat plaque in leg arteries above and below the knee. The firm's orbital atherectomy systems are used in peripheral and coronary commercial applications. Its OAS products include the Diamondback 360 Peripheral and Stealth 360 systems. Sales of Peripheral OAS contribute the majority of revenue. Cardiovascular systems generates the vast majority of its revenue in the United States.

Ratios

vs
industry
vs
history
Forward PE Ratio 476.19
CSII's Forward PE Ratio is ranked lower than
93% of the 55 Companies
in the Global Medical Devices industry.

( Industry Median: 25.06 vs. CSII: 476.19 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PB Ratio 6.88
CSII's PB Ratio is ranked lower than
83% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 2.94 vs. CSII: 6.88 )
Ranked among companies with meaningful PB Ratio only.
CSII' s PB Ratio Range Over the Past 10 Years
Min: 0.18  Med: 5.97 Max: 14.5
Current: 6.88
0.18
14.5
PS Ratio 3.89
CSII's PS Ratio is ranked lower than
65% of the 294 Companies
in the Global Medical Devices industry.

( Industry Median: 3.06 vs. CSII: 3.89 )
Ranked among companies with meaningful PS Ratio only.
CSII' s PS Ratio Range Over the Past 10 Years
Min: 0.24  Med: 2.59 Max: 7.6
Current: 3.89
0.24
7.6
Price-to-Free-Cash-Flow 47.28
CSII's Price-to-Free-Cash-Flow is ranked lower than
74% of the 111 Companies
in the Global Medical Devices industry.

( Industry Median: 28.08 vs. CSII: 47.28 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
CSII' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 45.36  Med: 81.75 Max: 172.72
Current: 47.28
45.36
172.72
Price-to-Operating-Cash-Flow 41.38
CSII's Price-to-Operating-Cash-Flow is ranked lower than
81% of the 138 Companies
in the Global Medical Devices industry.

( Industry Median: 19.79 vs. CSII: 41.38 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
CSII' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 39.68  Med: 68.02 Max: 123.16
Current: 41.38
39.68
123.16
EV-to-EBIT -871.24
CSII's EV-to-EBIT is ranked lower than
99.99% of the 179 Companies
in the Global Medical Devices industry.

( Industry Median: 23.37 vs. CSII: -871.24 )
Ranked among companies with meaningful EV-to-EBIT only.
CSII' s EV-to-EBIT Range Over the Past 10 Years
Min: -1117.4  Med: -14.85 Max: 9.1
Current: -871.24
-1117.4
9.1
EV-to-EBITDA 289.30
CSII's EV-to-EBITDA is ranked lower than
97% of the 190 Companies
in the Global Medical Devices industry.

( Industry Median: 17.75 vs. CSII: 289.30 )
Ranked among companies with meaningful EV-to-EBITDA only.
CSII' s EV-to-EBITDA Range Over the Past 10 Years
Min: -377  Med: -11.9 Max: 371
Current: 289.3
-377
371
EV-to-Revenue 3.65
CSII's EV-to-Revenue is ranked lower than
57% of the 306 Companies
in the Global Medical Devices industry.

( Industry Median: 3.38 vs. CSII: 3.65 )
Ranked among companies with meaningful EV-to-Revenue only.
CSII' s EV-to-Revenue Range Over the Past 10 Years
Min: -1.2  Med: 2.4 Max: 7.3
Current: 3.65
-1.2
7.3
Current Ratio 4.30
CSII's Current Ratio is ranked higher than
70% of the 325 Companies
in the Global Medical Devices industry.

( Industry Median: 2.67 vs. CSII: 4.30 )
Ranked among companies with meaningful Current Ratio only.
CSII' s Current Ratio Range Over the Past 10 Years
Min: 1.27  Med: 3.93 Max: 17.17
Current: 4.3
1.27
17.17
Quick Ratio 3.83
CSII's Quick Ratio is ranked higher than
73% of the 325 Companies
in the Global Medical Devices industry.

( Industry Median: 2.00 vs. CSII: 3.83 )
Ranked among companies with meaningful Quick Ratio only.
CSII' s Quick Ratio Range Over the Past 10 Years
Min: 1.18  Med: 3.47 Max: 17.17
Current: 3.83
1.18
17.17
Days Inventory 155.76
CSII's Days Inventory is ranked lower than
57% of the 294 Companies
in the Global Medical Devices industry.

( Industry Median: 139.39 vs. CSII: 155.76 )
Ranked among companies with meaningful Days Inventory only.
CSII' s Days Inventory Range Over the Past 10 Years
Min: 37.97  Med: 113.66 Max: 161.81
Current: 155.76
37.97
161.81
Days Sales Outstanding 48.69
CSII's Days Sales Outstanding is ranked higher than
79% of the 277 Companies
in the Global Medical Devices industry.

( Industry Median: 67.97 vs. CSII: 48.69 )
Ranked among companies with meaningful Days Sales Outstanding only.
CSII' s Days Sales Outstanding Range Over the Past 10 Years
Min: 47.38  Med: 54.78 Max: 61.98
Current: 48.69
47.38
61.98
Days Payable 99.45
CSII's Days Payable is ranked higher than
72% of the 265 Companies
in the Global Medical Devices industry.

( Industry Median: 59.71 vs. CSII: 99.45 )
Ranked among companies with meaningful Days Payable only.
CSII' s Days Payable Range Over the Past 10 Years
Min: 81.57  Med: 106.56 Max: 116.18
Current: 99.45
81.57
116.18

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -1.90
CSII's 3-Year Average Share Buyback Ratio is ranked higher than
67% of the 257 Companies
in the Global Medical Devices industry.

( Industry Median: -4.90 vs. CSII: -1.90 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CSII' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -242.8  Med: -22.3 Max: -1.9
Current: -1.9
-242.8
-1.9

Valuation & Return

vs
industry
vs
history
Price-to-Net-Cash 23.50
CSII's Price-to-Net-Cash is ranked lower than
70% of the 105 Companies
in the Global Medical Devices industry.

( Industry Median: 14.17 vs. CSII: 23.50 )
Ranked among companies with meaningful Price-to-Net-Cash only.
CSII' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 0.54  Med: 13.47 Max: 231.2
Current: 23.5
0.54
231.2
Price-to-Net-Current-Asset-Value 9.68
CSII's Price-to-Net-Current-Asset-Value is ranked lower than
66% of the 210 Companies
in the Global Medical Devices industry.

( Industry Median: 7.13 vs. CSII: 9.68 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
CSII' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 0.53  Med: 7.3 Max: 27.54
Current: 9.68
0.53
27.54
Price-to-Tangible-Book 7.20
CSII's Price-to-Tangible-Book is ranked lower than
69% of the 274 Companies
in the Global Medical Devices industry.

( Industry Median: 4.11 vs. CSII: 7.20 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
CSII' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.52  Med: 6.29 Max: 12.81
Current: 7.2
0.52
12.81
Price-to-Median-PS-Value 1.50
CSII's Price-to-Median-PS-Value is ranked lower than
82% of the 257 Companies
in the Global Medical Devices industry.

( Industry Median: 1.05 vs. CSII: 1.50 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
CSII' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.27  Med: 1.04 Max: 2.75
Current: 1.5
0.27
2.75
Earnings Yield (Greenblatt) % -0.12
CSII's Earnings Yield (Greenblatt) % is ranked lower than
54% of the 332 Companies
in the Global Medical Devices industry.

( Industry Median: 0.94 vs. CSII: -0.12 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
CSII' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -940.6  Med: -6.3 Max: 72.7
Current: -0.12
-940.6
72.7

More Statistics

Revenue (TTM) (Mil) $204.78
EPS (TTM) $ -0.06
Beta2.03
Short Percentage of Float2.43%
52-Week Range $23.00 - 33.11
Shares Outstanding (Mil)34.12

Analyst Estimate

Jun18
Revenue (Mil $)
EPS ($) 0.05
EPS without NRI ($) 0.05
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: 77
Positive ROAN
Positive CFROAY
Higher ROA yoyY
CFROA > ROAY
Lower Leverage yoyN
Higher Current Ratio yoyY
Less Shares Outstanding yoyY
Higher Gross Margin yoyY
Higher Asset Turnover yoyY

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}